167 related articles for article (PubMed ID: 12921980)
1. Soluble intercellular adhesion molecule-1 and interleukin-6 levels reflect endothelial dysfunction in patients with primary hypercholesterolaemia treated with atorvastatin.
Nawawi H; Osman NS; Annuar R; Khalid BA; Yusoff K
Atherosclerosis; 2003 Aug; 169(2):283-91. PubMed ID: 12921980
[TBL] [Abstract][Full Text] [Related]
2. High-dose atorvastatin therapy is required for significant improvement of endothelial function in heterozygous familial hypercholesterolaemic patients.
Brown SL; Raal FJ; Panz VR; Stevens BA; Veller MG
Cardiovasc J S Afr; 2004; 15(2):70-5. PubMed ID: 15148541
[TBL] [Abstract][Full Text] [Related]
3. Effect of atorvastatin on peripheral endothelial function and systemic inflammatory markers in patients with stable coronary artery disease.
Alber HF; Frick M; Süssenbacher A; Dörler J; Dichtl W; Stocker EM; Pachinger O; Weidinger F
Wien Med Wochenschr; 2007 Feb; 157(3-4):73-8. PubMed ID: 17340064
[TBL] [Abstract][Full Text] [Related]
4. Reduction in serum levels of adhesion molecules, interleukin-6 and C-reactive protein following short-term low-dose atorvastatin treatment in patients with non-familial hypercholesterolemia.
Nawawi H; Osman NS; Yusoff K; Khalid BA
Horm Metab Res; 2003 Aug; 35(8):479-85. PubMed ID: 12953165
[TBL] [Abstract][Full Text] [Related]
5. Levels of soluble cell adhesion molecules in patients with dyslipidemia.
Hackman A; Abe Y; Insull W; Pownall H; Smith L; Dunn K; Gotto AM; Ballantyne CM
Circulation; 1996 Apr; 93(7):1334-8. PubMed ID: 8641021
[TBL] [Abstract][Full Text] [Related]
6. Effects of atorvastatin monotherapy and simvastatin plus cholestyramine on arterial endothelial function in patients with severe primary hypercholesterolaemia.
Simons LA; Sullivan D; Simons J; Celermajer DS
Atherosclerosis; 1998 Mar; 137(1):197-203. PubMed ID: 9568752
[TBL] [Abstract][Full Text] [Related]
7. The effect of atorvastatin treatment on lipid profile and adhesion molecule levels in hypercholesterolemic patients: relation to low-density lipoprotein receptor gene polymorphism.
Bolewski A; Lipiecki J; Plewa R; Burchardt P; Siminiak T
Cardiology; 2008; 111(2):140-6. PubMed ID: 18376126
[TBL] [Abstract][Full Text] [Related]
8. Correlates of endothelial function and their relationship with inflammation in patients with familial hypercholesterolaemia.
van Haelst PL; van Doormaal JJ; Asselbergs FW; van Roon AM; Veeger NJ; Henneman MM; Smit AJ; Tervaert JW; May JF; Gans RO
Clin Sci (Lond); 2003 Jun; 104(6):627-32. PubMed ID: 12558496
[TBL] [Abstract][Full Text] [Related]
9. Leukocyte and endothelial adhesion molecules in patients with hypercholesterolemia: the effect of atorvastatin treatment.
Stulc T; Vrablík M; Kasalová Z; Marinov I; Svobodová H; Ceska R
Physiol Res; 2008; 57(2):185-194. PubMed ID: 17465700
[TBL] [Abstract][Full Text] [Related]
10. Changes in flow-mediated dilatation, cytokines and carotid arterial stenosis during aggressive atorvastatin treatment in normocholesterolemic patients.
Hsu HY; Wang PY; Chen YT; Sheu WH; Hu HH; Sheng WY
J Chin Med Assoc; 2005 Feb; 68(2):53-8. PubMed ID: 15759815
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin improves endothelial function and cardiac performance in patients with dilated cardiomyopathy: the role of inflammation.
Liu M; Wang F; Wang Y; Jin R
Cardiovasc Drugs Ther; 2009 Oct; 23(5):369-76. PubMed ID: 19636689
[TBL] [Abstract][Full Text] [Related]
12. Levels of adhesion molecules do not decrease after 3 months of statin therapy in moderate hypercholesterolaemia.
Jilma B; Joukhadar C; Derhaschnig U; Rassoul F; Richter V; Wolzt M; Dorner GT; Petternel V; Wagner OF
Clin Sci (Lond); 2003 Feb; 104(2):189-93. PubMed ID: 12546641
[TBL] [Abstract][Full Text] [Related]
13. Effects of atorvastatin on endothelial function and the expression of proinflammatory cytokines and adhesion molecules in young subjects with successfully repaired coarctation of aorta.
Brili S; Tousoulis D; Antonopoulos AS; Antoniades C; Hatzis G; Bakogiannis C; Papageorgiou N; Stefanadis C
Heart; 2012 Feb; 98(4):325-9. PubMed ID: 22076019
[TBL] [Abstract][Full Text] [Related]
14. [Effect of atorvastatin on endothelial function in patients with familial hypercholesterolemia].
Balakhonova TV; Pogorelova OA; Susekov AV; Kobylianskiĭ AG; Kuznetsova TV; Tvorogova MG; Masenko VP; Titov VN; Kukharchuk VV; At'kov OIu
Kardiologiia; 2002; 42(1):15-21. PubMed ID: 12494218
[TBL] [Abstract][Full Text] [Related]
15. Effects of atorvastatin treatment on sICAM-1 and plasma nitric oxide levels in hypercholesterolemic subjects.
Sardo MA; Castaldo M; Cinquegrani M; Bonaiuto M; Maesano A; Versace A; Spadaro M; Campo S; Nicocia G; Altavilla D; Saitta A
Clin Appl Thromb Hemost; 2002 Jul; 8(3):257-63. PubMed ID: 12361204
[TBL] [Abstract][Full Text] [Related]
16. E-selectin and TFPI are associated with carotid intima-media thickness in stable IHD patients: the baseline findings of the MIAMI study.
Porta B; Baldassarre D; Camera M; Amato M; Arquati M; Brusoni B; Fiorentini C; Montorsi P; Romano S; Tremoli E; Cortellaro M;
Nutr Metab Cardiovasc Dis; 2008 May; 18(4):320-8. PubMed ID: 17889518
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin improves metabolic control and endothelial function in type 2 diabetic patients: a placebo-controlled study.
Dalla Nora E; Passaro A; Zamboni PF; Calzoni F; Fellin R; Solini A
J Endocrinol Invest; 2003 Jan; 26(1):73-8. PubMed ID: 12602538
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients.
Ascer E; Bertolami MC; Venturinelli ML; Buccheri V; Souza J; Nicolau JC; Ramires JA; Serrano CV
Atherosclerosis; 2004 Nov; 177(1):161-6. PubMed ID: 15488879
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of the immune system in primary hypercholesterolaemia: effect of atorvastatin therapy.
Sampietro T; Bigazzi F; Rossi G; Dal Pino B; Puntoni MR; Sbrana F; Chella E; Bionda A
J Intern Med; 2005 Jun; 257(6):523-30. PubMed ID: 15910556
[TBL] [Abstract][Full Text] [Related]
20. [Correlation analysis between biochemical and biophysical markers of endothelium damage in children with diabetes type 1].
Głowińska-Olszewska B; Urban M; Tołwińska J; Peczyńska J; Florys B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(4):221-7. PubMed ID: 16232360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
